Skip to main content

Peer Review reports

From: ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo

Original Submission
25 Jan 2008 Submitted Original manuscript
11 Mar 2008 Reviewed Reviewer Report - Jong-Wan Park
12 Mar 2008 Reviewed Reviewer Report - Nicola Mabjeesh
29 Apr 2008 Author responded Author comments - Oliver Stoeltzing
Resubmission - Version 2
29 Apr 2008 Submitted Manuscript version 2
29 Apr 2008 Author responded Author comments - Oliver Stoeltzing
Resubmission - Version 3
29 Apr 2008 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
14 May 2008 Reviewed Reviewer Report - Jong-Wan Park
26 May 2008 Reviewed Reviewer Report - Nicola Mabjeesh
6 Jun 2008 Author responded Author comments - Oliver Stoeltzing
Resubmission - Version 5
6 Jun 2008 Submitted Manuscript version 5
20 Jun 2008 Author responded Author comments - Oliver Stoeltzing
Resubmission - Version 6
20 Jun 2008 Submitted Manuscript version 6
3 Jul 2008 Reviewed Reviewer Report - Nicola Mabjeesh
16 Jul 2008 Author responded Author comments - Oliver Stoeltzing
Resubmission - Version 7
16 Jul 2008 Submitted Manuscript version 7
22 Jul 2008 Author responded Author comments - Oliver Stoeltzing
Resubmission - Version 8
22 Jul 2008 Submitted Manuscript version 8
Publishing
23 Jul 2008 Editorially accepted
23 Jul 2008 Article published 10.1186/1471-2407-8-206

You can find further information about peer review here.

Back to article page